Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-881P (RNA, U6 small nuclear 881, pseudogene) is a pseudogene identified in the human genome, mapping to cytoband 9q34.13. It is cataloged in multiple gene databases (NCBI Gene: 106479956, Ensembl: ENSG00000252622, HGNC:47844), but does not encode a functional RNA or protein, nor does it appear to have any established biological activity or disease association. Pseudogenes are DNA segments similar to known genes but rendered non-functional through mutation or lack of regulatory elements, often serving as remnants of evolutionary processes. In rare cases, pseudogenes may have regulatory or ceRNA functions, but no such activity has been assigned to RNU6-881P[1][3][4][5][7]. RNU6-881P is not a valid therapeutic target and is classified as a pseudogene without known functional activity, disease roles, or drug interactions. Its listing as a target is incorrect.
None applicable. There is no known mechanism for any drugs acting via RNU6-881P, as it is not a functional molecule[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 881, pseudogene (RNU6-881P).